Quality Improvement of Person-Centered Care for Maternal Health in Public Facilities in India, Phase 2 (SPARQINDIA2)

December 19, 2019 updated by: University of California, San Francisco

Strengthening Person-centered Accessibility, Respect, and Quality of Maternal Health Services in India, Phase 2

Evaluating the spread of a quality improvement (QI) change package working to improve person-centered care (PCC) for maternal health (MH) services.

Study Overview

Detailed Description

After implementing a quality improvement (QI) collaborative in public facilities in Uttar Pradesh, India, a second phase was done to evaluate if the "change package" developed during phase one could be implemented in similar facilities to improve the quality of person-centered care (PCC) for a maternal health (MH) services.

Study Type

Interventional

Enrollment (Actual)

1971

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Uttar Pradesh
      • Lucknow, Uttar Pradesh, India
        • Population Services International

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria for Women:

  • Women aged 18-49 years old
  • Who agreed to participate
  • Who delivered a baby at the facility where data collection is taking place within the last 7 days

Exclusion Criteria for Women:

  • Not a women aged 18-49
  • Did not agree to participate
  • Did not deliver a baby at the facility where data collection is taking place within the last 7 days

Inclusion Criteria for Providers:

  • Agreed to participate
  • Purposive sampling
  • Permanent staff at the facility

Exclusion Criteria for Providers:

  • Did not agree to participate
  • Not permanent staff at the facility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control - Patient
Participants who receive maternal health services at a facility not participating in the Quality Improvement Intervention or implementing the change package
Experimental: Sustaining - Patients
Participants who received maternal health services at a facility where a quality improvement collaborative had been implemented
Sustain improvements during QI collaborative focused on PCC
Experimental: Spread - Patients
Participants who received maternal health services at a facility that was provided a change package of ideas developed during the quality improvement collaborative (in phase 1) and used to make improvements on person-centered care
Implement change package developed during QI Collaborative
No Intervention: Control - Providers
Providers who work at a facility not participating in the Quality Improvement Intervention or implementing the change package
Experimental: Sustaining - Providers
Providers who work at a facility where a quality improvement collaborative had been implemented
Sustain improvements during QI collaborative focused on PCC
Experimental: Spread - Providers
Participants who work at a facility that was provided a change package of ideas developed during the quality improvement collaborative (in phase 1) and used to make improvements on person-centered care
Implement change package developed during QI Collaborative

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Person-Centered Maternal Health Scale Score
Time Frame: baseline
Survey conducted with women: self-report of experiences of care. Possible range 0-100; higher the score the better the experience of care
baseline
Person-Centered Maternal Health Scale Score
Time Frame: About 12 month post baseline
Survey conducted with women: self-report of experiences of care. Possible range 0-100; higher the score the better the experience of care
About 12 month post baseline
Person-Centered Scale Score
Time Frame: baseline
Survey conducted with providers: self-report of perceptions of care. Possible range 0-100; higher the score the better the experience of care
baseline
Person-Centered Scale Score
Time Frame: About 12 months post baseline
Survey conducted with providers: self-report of perceptions of care. Possible range 0-100; higher the score the better the experience of care
About 12 months post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dominic Monatgu, DrPH, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2018

Primary Completion (Actual)

June 29, 2019

Study Completion (Actual)

June 29, 2019

Study Registration Dates

First Submitted

December 18, 2019

First Submitted That Met QC Criteria

December 19, 2019

First Posted (Actual)

December 23, 2019

Study Record Updates

Last Update Posted (Actual)

December 23, 2019

Last Update Submitted That Met QC Criteria

December 19, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15-18008_QI India_Phase2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reproductive Health

Clinical Trials on Person-Centered Care Quality Improvement Collaborative Sustain

3
Subscribe